Fluoxetine
What it is
We have not added a short description yet.
Why it is on this page
People: source-defined study populations
DailyMed fluoxetine hydrochloride label · checked Oct 16, 2026
Relationship: label-reported clinical studies for the Need
Statement scope
- Jurisdiction
United States label
- Need
Panic Disorder
- Population
source-defined study populations
Source collection coverage: country:US
Pointer: /sections/4
Supporting passage: The effectiveness of fluoxetine in the treatment of Panic Disorder was demonstrated in 2 double-blind, randomized, placebo-controlled, multicenter studies of adult outpatients who had a primary diagnosis of Panic Disorder (DSM-IV), with or without agoraphobia.
Open sourceSource: DailyMed fluoxetine hydrochloride label. Checked Oct 16, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/f274f102-67ec-46e7-b248-533be2e3003b.xml
Research for Panic Disorder
Research suggests benefit in this exact scope
Published Sep 20, 2026 · revision 1
What research says
The retained fluoxetine label reports two randomized, placebo-controlled studies for panic disorder; this assessment does not determine personal suitability or compare fluoxetine with every alternative.
DailyMed fluoxetine hydrochloride label · checked Oct 16, 2026
Relationship: supports bounded conclusion
Statement scope
- Jurisdiction
United States label
- Need
Panic Disorder
- Population
source-defined study populations
Source collection coverage: country:US
Pointer: /sections/4
Supporting passage: The effectiveness of fluoxetine in the treatment of Panic Disorder was demonstrated in 2 double-blind, randomized, placebo-controlled, multicenter studies of adult outpatients who had a primary diagnosis of Panic Disorder (DSM-IV), with or without agoraphobia.
Open sourceSource: DailyMed fluoxetine hydrochloride label. Checked Oct 16, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/f274f102-67ec-46e7-b248-533be2e3003b.xml
Compared with the others: Not directly compared. We show each option’s own research.